Company: GANX
Filing Date: 2025-05-28
Form Type: S-3
Source: 0001104659-25-053619
Chunk: 46

Company: Gain Therapeutics, Inc.
Filing Date: 2025-05-28
Form: S-3
Chunk 46
---
 without the other, his or her true and lawful attorneys-in-fact and agents, each with full power of substitution and resubstitution, for such person and in his or her name, place and stead, in any and all capacities, to sign any amendments to this registration statement, and to sign any registration statement for the same offering covered by this registration statement, including post-effective amendments or registration statements filed pursuant to Rule 462(b) under the Securities Act of 1933, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming that each of said such attorneys-in-fact and agents or his substitute or substitutes, may do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

| ​ 
 ​ 
 ​ | Signature             
 /s/ Gene Mack         
 ​                     
 Gene Mack             
 /s/ Gianluca Fuggetta 
 ​                     
 Gianluca Fuggetta     | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Title                                                                      
 Chief Executive Officer and Director (Principal Executive Officer)         
 Senior Vice President Finance (Principal Financial and Accounting Officer) | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Date         
 May 28, 2025 
 May 28, 2025 | ​ 
 ​ 
 ​ |
|:--|:----------------------|:--|:--|:---------------------------------------------------------------------------|:--|:--|:-------------|:--|
| ​ | /s/ Khalid Islam      
 ​                     
 Khalid Islam          | ​ | ​ | Director                                                                   | ​ | ​ | May 28, 2025 | ​ |
| ​ | /s/ Dov Goldstein     
 ​                     
 Dov Goldstein         | ​ | ​ | Director                                                                   | ​ | ​ | May 28, 2025 | ​ |
| ​ | /s/ Hans Peter Hasler 
 ​                     
 Hans Peter Hasler     | ​ | ​ | Director                                                                   | ​ | ​ | May 28, 2025 | ​ |
| ​ | /s/ Gwen Melincoff    
 ​                     
 Gwen Melincoff        | ​ | ​ | Director                                                                   | ​ | ​ | May 28, 2025 | ​ |
| ​ | /s/ Claude Nicaise    
 ​                     
 Claude Nica